Management of Spasticity in Children with Cerebral Palsy

Cerebral palsy is the most common cause of spasticity and physical disability in children and spasticity is one of the commonest problems in those with neurological disease. The management of spasticity in children with cerebral palsy requires a multidisciplinary effort and should be started as early as possible. There are a number of treatments available for the management of spasticity. This article reviews the variety of options available for the clinical management of spasticity.

[1]  Günes Yavuzer,et al.  Effects of ankle-foot orthoses on hemiparetic gait , 2003, Clinical rehabilitation.

[2]  J. Quinlan,et al.  Dystrophinopathies: clarification and complication. , 1996, Journal of child neurology.

[3]  D. Kinnett.  Botulinum Toxin A Injections in Children: Technique and Dosing Issues , 2004, American journal of physical medicine & rehabilitation.

[4]  K. Jaffe,et al.  EFFECTS OF ‘TONE‐REDUCING’ VS. STANDARD PLASTER‐CASTS ON GAIT IMPROVEMENT OF CHILDREN WITH CEREBRAL PALSY , 1988, Developmental medicine and child neurology.

[5]  J. Gracies.  Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. , 2001, Physical medicine and rehabilitation clinics of North America.

[6]  C. A. Trombly,et al.  Occupational Therapy for Physical Dysfunction , 1989 .

[7]  J. Janosky,et al.  Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. , 1995, Pediatric neurosurgery.

[8]  Shashi Ranjan,et al.  Efficacy of occupational therapy and serial casting in lower limbs of cerebral palsy children administered with phenol nerve block , 2011 .

[9]  E. M. Goldstein.  Spasticity Management: An Overview , 2001, Journal of child neurology.

[10]  R. K. Beals,et al.  Developmental Changes in the Femur and Acetabulum in Spastic Paraplegia and Diplegia , 1969, Developmental medicine and child neurology.

[11]  M. Pranzatelli.  Topical Review: Antidyskinetic Drug Therapy for Pediatric Movement Disorders , 1996 .

[12]  J. Cottalorda,et al.  The help guide to cerebral palsy Nadire Berker et Selim Yalcin Avrupa Medical Bookship Co. Ldt and Global-Help organization, 2005, 144 pages. ISBN: 975-6257-12-1. , 2006 .

[13]  C. Buckon,et al.  Comparison of three ankle-foot orthosis configurations for children with spastic hemiplegia. , 2007, Developmental medicine and child neurology.

[14]  W. Peacock,et al.  Selective posterior rhizotomy: evolution of theory and practice. , 1991, Pediatric neurosurgery.

[15]  D. R. Curtis,et al.  Central effects of -(p-chlorophenyl)-?-aminobutyric acid , 1974 .

[16]  D. Lumsden,et al.  Treating complex movement disorders in children with cerebral palsy , 2009, The Ulster medical journal.

[17]  D. M. Simpson,et al.  Botulinum toxin type A in the treatment of upper extremity spasticity , 1996, Neurology.

[18]  Rhoda Priest Erhardt.  Developmental hand dysfunction : theory assessment treatment , 1994 .

[19]  N. Lannin,et al.  A comparison of goal attainment scaling and the Canadian occupational performance measure for paediatric rehabilitation research , 2006, Pediatric rehabilitation.

[20]  J. Bugaresti,et al.  Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group. , 1994, Neurology.

[21]  J. Buchan.  THERAPEUTIC HEAT. , 1965, The Practitioner.

[22]  Hamid Dalvand,et al.  The efficacy of botulinum toxin type A injection in the hamstring and calf muscles with and without serial foot casting in gait improvement in children with cerebral palsy , 2011 .

[23]  M. Pranzatelli.  Oral Pharmacotherapy for the Movement Disorders of Cerebral Palsy , 1996, Journal of child neurology.

[24]  Richard W. Bohannon,et al.  Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.

[25]  J. Lehmann,et al.  Influence of cryotherapy on spasticity at the human ankle. , 1993, Archives of physical medicine and rehabilitation.

[26]  S. Hinderer,et al.  Physiologic and clinical monitoring of spastic hypertonia. , 2001, Physical medicine and rehabilitation clinics of North America.

[27]  L. Mutch,et al.  Cerebral Palsy Epidemiology: Where are We Now and Where are We Going? , 1992, Developmental medicine and child neurology.

[28]  D. Matthews,et al.  [Management of spasticity in children with cerebral palsy]. , 2009, Acta orthopaedica et traumatologica turcica.

[29]  R. Chan,et al.  Effect of Botulinum Toxin Type A on Cerebral Palsy with Upper Limb Spasticity , 2003, American journal of physical medicine & rehabilitation.

[30]  Hamid Dalvand,et al.  Effect of the Bobath Technique, Conductive Education and Education to Parents in Activities of Daily Living in Children with Cerebral Palsy in Iran: , 2009 .

[31]  V. Hendricks-Ferguson,et al.  Selective dorsal rhizotomy to decrease spasticity in cerebral palsy. , 1995, AORN journal.

[32]  J. Richards,et al.  The efficacy of tone-reducing features in orthotics on the gait of children with spastic diplegic cerebral palsy. , 2000, Journal of pediatric orthopedics.

[33]  D. Cooperman,et al.  Hip Dislocation in Spastic Cerebral Palsy: Long‐Term Consequences , 1987, Journal of pediatric orthopedics.

[34]  R. Calderón-González,et al.  Botulinum toxin A in management of cerebral palsy. , 1994, Pediatric neurology.

[35]  K. Song,et al.  Ankle-foot orthoses for preambulatory children with spastic diplegia. , 1997, Journal of pediatric orthopedics.

[36]  Shamsoddini Alireza.  Comparison between the effect of neurodevelopmental treatment and sensory integration therapy on gross motor function in children with cerebral palsy. , 2010 .

[37]  B. Bussel,et al.  [Management of increase in spasticity in patients with intrathecal baclofen pumps]. , 2007, Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique.

[38]  P. Milla,et al.  A Controlled Trial of Baclofen in Children with Cerebral Palsy , 1973, The Journal of international medical research.

[39]  M. Hallett,et al.  Classification and definition of disorders causing hypertonia in childhood. , 2003, Pediatrics.

[40]  C. Morris.  Orthotic Management of Children with Cerebral Palsy , 2002 .

[41]  L. A. Koman,et al.  The Use of Botulinum Toxin in the Management of Cerebral Palsy in Pediatric Patients , 1993 .

[42]  S. Gould.  The Panda's Thumb , 1980 .

[43]  Beverly D Cusick.  Splints and Casts , 1988 .

[44]  B. Russman,et al.  Cerebral palsy: A rational approach to a treatment protocol, and the role of botulinum toxin in treatment , 1997, Muscle & nerve. Supplement.

[45]  S. Davison,et al.  Implantable Baclofen Pump as an Adjuvant in Treatment of Pressure Sores , 2003, Annals of Plastic Surgery.

[46]  Ann Tilton,et al.  Management of spasticity in children with cerebral palsy. , 2004, Seminars in pediatric neurology.

[47]  R. Penn,et al.  The effects of intrathecally administered baclofen on function in patients with spasticity. , 1995, Physical therapy.

[48]  J. Preisser,et al.  Trends in Mortality and Cerebral Palsy in a Geographically Based Cohort of Very Low Birth Weight Neonates Born Between 1982 to 1994 , 1998, Pediatrics.

[49]  A P Cosgrove,et al.  BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY , 1994, Developmental medicine and child neurology.

[50]  I. Novak.  Physiotherapy and Occupational Therapy for People with Cerebral Palsy: A Problem-Based Approach to Assessment and Management , 2010 .

[51]  Paula Kramer PhD Otr Faota.  Frames of Reference for Pediatric Occupational Therapy , 2009 .

[52]  Richard C. E. Anderson,et al.  Management of childhood spasticity: a neurosurgical perspective. , 2006, Pediatric annals.

[53]  J. Jankovic,et al.  Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias , 1988, Neurology.

[54]  A. Shamsoddini,et al.  Effect of sensory integration therapy on gross motor function in children with cerebral palsy. , 2009 .

[55]  Garth R. Johnson,et al.  Upper Motor Neurone Syndrome and Spasticity: Clinical Management and Neurophysiology , 2008 .

[56]  P. Arlien‐Søborg,et al.  THE MODE OF ACTION OF THE GABA DERIVATIVE BACLOFEN IN HUMAN SPASTICITY , 1974, Acta neurologica Scandinavica.

[57]  R. A. Davidoff,et al.  The effects on synaptic of Lioresal activity in the isolated spinal cord , 1974, Neurology.

[58]  M. Sharpe,et al.  Brunnstrom therapy: Is it still relevant to stroke rehabilitation? , 1994 .

[59]  R. Katz.  Management of Spasticity , 1988, American journal of physical medicine & rehabilitation.

[60]  M. Law,et al.  The Effectiveness of Casts, Orthoses, and Splints for Children with Neurological Disorders , 2002 .

[61]  J. Bryce.  The management of spasticity in children. , 1976, Physiotherapy.

[62]  R. Sahaf,et al.  Hypertonicity in Children with Cerebral Palsy: a New Perspective , 2011 .

[63]  L. A. Koman,et al.  Neuromuscular Blockade in the Management of Cerebral Palsy , 1996, Journal of child neurology.

[64]  B. Ashworth.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. , 1964, The Practitioner.

[65]  Stephen M. Haley,et al.  Pediatric evaluation of disability inventory (PEDI) : development, standardization and administration manual , 1998 .

[66]  J. Meythaler.  Concept of spastic hypertonia. , 2001, Physical medicine and rehabilitation clinics of North America.

[67]  M. Sánchez-Ledesma,et al.  Chronic intrathecal baclofen administration in severe spasticity. , 1990, Stereotactic and functional neurosurgery.

[68]  B. Bussel,et al.  Conduite à tenir devant une recrudescence de spasticité chez un patient porteur d'une pompe à baclofène , 2007 .

[69]  R. Joynt,et al.  Dantrolene Sodium Suspension in Treatment of Spastic Cerebral Palsy , 1980, Developmental medicine and child neurology.

[70]  L. A. Koman,et al.  Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation , 1993, Journal of pediatric orthopedics.

[71]  N. N. Chan.  Physiotherapy in Spasticity Management for Children with Cerebral Palsy , 2011 .

[72]  F. Chiarelli,et al.  Pharmacotherapy of spasticity in children with cerebral palsy. , 2006, Pediatric neurology.

[73]  B. L. Olivett,et al.  Grasp and pinch strength in children 5 to 12 years old. , 1984, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[74]  R. A. Davidoff.  Antispasticity drugs: Mechanisms of action , 1985, Annals of neurology.

[75]  C. Marsden,et al.  Torsion dystonia , 1986, Neurology.

[76]  Larry H. Ludlow,et al.  Pediatric Evaluation of Disability Inventory , 1994 .

[77]  L. Root,et al.  Hip adductor transfer compared with adductor tenotomy in cerebral palsy. , 1981, The Journal of bone and joint surgery. American volume.

[78]  M. Pierrynowski,et al.  Use of orthoses lowers the O(2) cost of walking in children with spastic cerebral palsy. , 2001, Medicine and science in sports and exercise.

[79]  David R. Beukelman,et al.  Augmentative and Alternative Communication: Management of Severe Communication Disorders in Children and Adults , 1995 .

[80]  H. Graham,et al.  Upper Motor Neurone Syndrome and Spasticity: Management of spasticity in children , 2008 .

[81]  The Impacts of Hinged and Solid Ankle-Foot Orthoses on Standing and Walking in Children with Spastic Diplegia , 2013, Iranian journal of child neurology.

[82]  S. Levitt.  Proprioceptive neuromuscular facilitation techniques in cerebral palsy. , 1966, Physiotherapy.

[83]  J. Birns,et al.  Management of Spasticity , 2015 .